Equity of access to innovative drugs and sustainability of pharmaceutical expenditure

被引：0
|
作者：
Eandi, Mario
机构：
来源：
FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS | 2010年 / 11卷 / 02期
关键词：
D O I：
10.7175/fe.v11i2.180
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [31] From patent to patient: analysing access to innovative cancer drugs
    Sharpe, Eva
    Hoey, Richard
    Yap, Christina
    Workman, Paul
    DRUG DISCOVERY TODAY, 2020, 25 (09) : 1561 - 1568
  • [32] TIME TO MARKET ACCESS FOR INNOVATIVE DRUGS IN THE UK, FRANCE, AND BELGIUM
    Maervoet, J.
    Toumi, M.
    VALUE IN HEALTH, 2012, 15 (07) : A312 - A312
  • [33] Open access to innovative drugs: Treatment substitutions or treatment expansion?
    McCombs, JS
    Mulani, P
    Gibson, PJ
    HEALTH CARE FINANCING REVIEW, 2004, 25 (03): : 35 - 53
  • [34] Medicare And Telehealth: Delivering On Innovation's Promise For Equity, Quality, Access, And Sustainability
    Seshamani, Meena
    HEALTH AFFAIRS, 2022, 41 (05) : 651 - 653
  • [35] Weighing in on the Scale of Justice for Equity and Access to Weight-management Drugs
    Maron, Jill L.
    CLINICAL THERAPEUTICS, 2023, 45 (03) : 195 - 196
  • [36] Equity in Education Expenditure in Thailand
    Cuesta, Jose
    Madrigal, Lucia
    DEVELOPMENT POLICY REVIEW, 2014, 32 (02) : 239 - 258
  • [37] Accelerating access to innovative oncology drugs: Insights from France's early access reform
    Martin, T.
    Bayle, A.
    Marabelle, A.
    Massard, C. P.
    Borget, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S943 - S943
  • [38] RESEARCH EXPENDITURE IN PHARMACEUTICAL INDUSTRY
    不详
    NATURE, 1964, 202 (492) : 140 - &
  • [39] EU PHARMACEUTICAL EXPENDITURE FORECAST
    Remuzat, C.
    Toumi, M.
    Vataire, A. L.
    Cetinsoy, L.
    VALUE IN HEALTH, 2013, 16 (03) : A254 - A255
  • [40] Skip pattern approach toward the early access of innovative anticancer drugs
    Apolone, G.
    Ardizzoni, A.
    Biondi, A.
    Bortolami, A.
    Cardone, C.
    Ciniselli, C. M.
    Conte, P.
    Crippa, C.
    de Braud, F.
    Duca, M.
    Gori, S.
    Gritti, G.
    Inno, A.
    Luksch, R.
    Lussana, F.
    Maio, M.
    Pasello, G.
    Perrone, F.
    Rambaldi, A.
    Rossi, G.
    Signorelli, D.
    Soverini, G.
    Valente, M.
    Verderio, P.
    Buzzetti, G.
    ESMO OPEN, 2021, 6 (04)
12345